31 January 2025
31 January 2025
During a Senate HELP Committee hearing, Robert F. Kennedy Jr. stated that President Trump is dedicated to bringing drug manufacturing "back home".
Charity organisation Sickle Cell Society has described the recommendation as a “major breakthrough” for sickle cell patients.
The pathway allows medicine developers to work with the regulators, the NHS and health technology assessment bodies.
The FDA has approved the therapy for administration twice daily.
The decision was unanimously reached by the company’s board of directors.
Okuzawa has been with the company since 1986.
Merging industry-leading business intelligence & award-winning journalism, this is an unrivalled opportunity for engagement with B2B professionals across a network of 40+ leading media websites.
Steer your business strategy with key data and insights from our latest market research reports and company profiles. Not ready to buy? Start small by downloading a sample report first.
Give your business an edge with our leading industry insights.
